Ana Zanoletty is the Head of Clinical Trials Transformation at the EMA where she leads the European clinical trials transformation initiative Accelerating Clinical Trials in the EU (ACT EU). In her role Ana also oversees the change management activities related to the implementation of the EU Clinical Trials Regulation and the Clinical Trials Information System (CTIS), and support to EU Member States. Prior to taking on this role, Ana was the programme manager for ACT EU. She joined EMA 20 years ago and has extensive experience in pre- and post-marketing authorisation procedures. Prior to joining the EMA, she worked for several years in clinical research within the pharmaceutical industry. Ana has a diploma in Dietetics and Human Nutrition, followed by a BSc in Pharmacy.